Navigation Links
Europe to tackle brain disorder research by linking industry, academia
Date:11/27/2007

Attempts to cure brain-related disorders have proved less successful than therapies for other major conditions such as heart cancer, even though just as many people suffer from them. About 600 million worldwide each year are afflicted by depression alone, more than any other condition except heart disease, and yet of those given existing drugs, only half recover.

Furthermore progress treating depression as well as other major brain disorders has stalled. This stark fact lies behind an ambitious European proposal to revive the field. The proposal, to be presented at EuroBioForum, in Lisbon in December 2007, aims to develop a ground breaking multi-disciplinary research project which would propel Europe to the head of global research into the crucial role of neurotransmitters in brain disorders. Bringing together the relevant specialisms in chemistry, radio-chemistry, in vivo modelling, and above all PET and SPECT scanning, the project would exploit recent advances both in PET (Positron Emission Tomography), and SPECT (Single Photon Emission Computer Tomography), enabling metabolic activity such as levels of neurotransmitters to be determined with greater accuracy in space and quantity.

The objective is to develop new methods to identify the release of neurotransmitters such as noradrenaline, serotonin, acetylcholine, and endorphins, in the brain and so examine their role in major brain disorders. This in turn will enable more effective therapies to be developed than current drugs, which often fail to work, according to the projects leader David Nutt, Professor of Psychopharmacology at the University of Bristol, UK. Professor Nutt is presenting his vision for this groundbreaking project at the EuroBioForum conference, which is organised by the European Science Foundation (ESF) with support from the European Commission.

The programme has great potential for human health given the vast number of people affected, but as Professor Nutt poi
'/>"/>

Contact: Dr. Fiona Kernan
fkernan@esf.org
33-388-762-180
European Science Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Eligard(R) six-month formulation successfully completes European approval procedure
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Medical Services International Inc. Completes Testing for European Union (EU) Application
4. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
5. Europe-wide Researchers Night
6. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
7. Launch of second European Cancer Research Funding survey
8. Cancer control in Europe works; now it is time to extend it to poorer countries
9. Political decisions harming cancer treatment in Europe
10. European directive will halt use of MRI scans; cancer diagnosis and treatment will suffer
11. Stille and Enova Form Strategic Partnership to Introduce Worlds Brightest LED Cordless Surgical Headlights Into Europe and Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/30/2014)... Lauderdale, FL (PRWEB) October 30, 2014 ... US Joint Commission Accredited teleradiology and specialty telemedicine ... that in addition to its existing teleradiology services ... multispecialty second opinion and expert telemedicine services, to ... Texas. , As a result of this innovative ...
(Date:10/30/2014)... The annual meeting of The North ... on Saturday, October 18th, marking the end of the ... NAMS is North America’s leading non-profit organization dedicated to ... women during midlife and beyond through an understanding of ... thought leaders from fields as varied as gynecology, sociology, ...
(Date:10/30/2014)... When it comes to heart disease, a new study finds ... they have symptoms that spell trouble. "The main danger ... more severe or advanced stage of heart disease, there are ... Fulbright Scholar and research fellow at the Harvard School of ... and Stroke Foundation of Canada. In the study, researchers ...
(Date:10/30/2014)... HealthDay Reporter WEDNESDAY, Oct. 29, 2014 (HealthDay ... your health, a new study reports. Previous research has ... and prevent osteoporosis. These benefits to bone health have led ... healthy diet. But this new study found that drinking ... from bone fractures, and was linked to an overall higher ...
(Date:10/30/2014)... 29, 2014 (HealthDay News) -- Americans, opinions about the ... a new study finds. Democratic voters are strongly ... to the researchers. Almost three-quarters of Democrats want the ... percent want Congress to implement the current law, while ... ACA. Among Independent voters, one-third want the law ...
Breaking Medicine News(10 mins):Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 2Health News:USARAD HOLDINGS INC, SECONDOPINIONS.COM® Pioneers Specialty On-Demand Telemedicine And Second Opinion Service At Houston-Based, Mission Bend Freestanding ER Chain 3Health News:Highlights from The North American Menopause Society 25th Annual Meeting 2Health News:Highlights from The North American Menopause Society 25th Annual Meeting 3Health News:Women Often Ignore Signs of Heart Trouble 2Health News:Is Milk Your Friend or Foe? 2Health News:Is Milk Your Friend or Foe? 3Health News:Voters' Views on Obamacare Split Along Party Lines 2
... Your Way, Contest and More than ... $10,000 in Cash and Prizes, HOFFMAN ESTATES, ... is the grand prize winner of the,annual "New Day Your Way" contest, ... and achieve their fitness goals,in 2008. During the 12-week contest, Kmart provided ...
... Researchers from the John Innes Centre and the University ... function of an enzyme which is involved in decorating ... variety of different carbohydrate molecules attached to them which ... the target organism or overcome resistance. By manipulating ...
... iron and offers a good set of proteins. This ... Eklund-Jonsson at the Department of Food Science, Chalmers University of ... a whole-grain product with high folate content. It is ... cardiovascular diseases, and it is also believed that it protects ...
... More Than $270 Million in Combined ... WALTHAM, Mass., May 28 Decision Resources, one ... pharmaceutical and,healthcare issues, forecasts that the Chinese type 2 ... to the new Emerging Markets report,entitled Type 2 Diabetes ...
... reach of drugs , , WEDNESDAY, May 28 (HealthDay News) ... provides a "hideout" for HIV during drug treatment and is ... cells (FDCs) are located throughout the body in specialized sites ... and Johns Hopkins School of Medicine. , FDCs act as ...
... of Recent Acquisitions; Continued Focus on ... Operational Efficiencies, SHENZHEN, ... NPD ) (,Nepstar, or ,the Company,), the,largest retail drugstore chain in ... March 31, 2008., Financial Highlights, For the first ...
Cached Medicine News:Health News:The Weight Is Over: Five Winners Lose 194 Pounds as Kmart Encourages 24,000 Americans to Achieve Healthier Lifestyle 2Health News:China's Type 2 Diabetes Drug Market Will More than Triple by 2012 2Health News:Scientists Break Into HIV 'Hideout' 2Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 2Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 3Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 4Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 5Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 6Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 7Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 8Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 9Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 10Health News:China Nepstar Chain Drugstore Reports Net Income Growth of 304.4% for First Quarter 2008 11
(Date:10/30/2014)... 29, 2014  BioMed Realty Trust, Inc. (NYSE: ... focusing on life sciences, today announced financial results ... Third Quarter 2014 Highlights Financial and ... transactions during the quarter representing approximately 657,700 square ... the third quarter of approximately 219,700 square feet; ...
(Date:10/27/2014)... MENLO PARK, Calif. , Oct. 27, 2014 /PRNewswire/ ... isolation of blood flow and delivery of fluids to ... the RenovoRx Board of Directors has appointed Shaun ... additional Member of the RenovoRx Board of Directors. Bagai ... medical technology industry. Bagai joined RenovoRx in ...
(Date:10/27/2014)... , Oct. 27, 2014 Research and Markets ... Vaccines Market 2014-2018" report to their offering. ... caused by a variant of the swine H1N1 virus, known ... which infects nose, throat, and lungs. H1N1 virus is an ... infect different animal species such as humans, swine, birds, seals, ...
Breaking Medicine Technology:BioMed Realty Trust Reports Third Quarter 2014 Financial Results 2BioMed Realty Trust Reports Third Quarter 2014 Financial Results 3BioMed Realty Trust Reports Third Quarter 2014 Financial Results 4BioMed Realty Trust Reports Third Quarter 2014 Financial Results 5BioMed Realty Trust Reports Third Quarter 2014 Financial Results 6BioMed Realty Trust Reports Third Quarter 2014 Financial Results 7BioMed Realty Trust Reports Third Quarter 2014 Financial Results 8BioMed Realty Trust Reports Third Quarter 2014 Financial Results 9BioMed Realty Trust Reports Third Quarter 2014 Financial Results 10BioMed Realty Trust Reports Third Quarter 2014 Financial Results 11BioMed Realty Trust Reports Third Quarter 2014 Financial Results 12BioMed Realty Trust Reports Third Quarter 2014 Financial Results 13BioMed Realty Trust Reports Third Quarter 2014 Financial Results 14BioMed Realty Trust Reports Third Quarter 2014 Financial Results 15BioMed Realty Trust Reports Third Quarter 2014 Financial Results 16BioMed Realty Trust Reports Third Quarter 2014 Financial Results 17BioMed Realty Trust Reports Third Quarter 2014 Financial Results 18BioMed Realty Trust Reports Third Quarter 2014 Financial Results 19BioMed Realty Trust Reports Third Quarter 2014 Financial Results 20BioMed Realty Trust Reports Third Quarter 2014 Financial Results 21RenovoRx Board Names Shaun R. Bagai as CEO 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 2Global H1N1 Vaccines Market 2014-2018: Key Vendors are AstraZeneca, GlaxoSmithKline, Novartis and Sanofi Pasteur 3
... Digital Assent, provider of the award-winning PatientPad® self-service ... that it has appointed Frank Garland as vice president ... Garland will focus on increasing the digital advertising and ... the company,s New York sales office. "Frank ...
... Oct. 20, 2011 Bend Research Inc. ( www.bendresearch.com ... has announced that John McLeod has joined the company ... http://photos.prnewswire.com/prnh/20111020/CL87178 ) McLeod was formerly Director ... six years, where his strategic vision is credited with ...
Cached Medicine Technology:Digital Assent Names Frank Garland Vice President of Advertising Sales 2Bend Research Announces New Chief Financial Officer 2
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... lightweight brace is designed for the ... fractures. The anatomically correct design achieves ... for optimal control of ulnar segments. ... motion is permitted to prevent problems ...
Finger /Thumb Splint has a stay that may be shaped to hold finger or thumb in exact degree of flexion. It also has a contact closure....
... joint or DIP joint flexioncontractures of any degree. ... gel-lining cushions injured fingers so treatment to straighten ... more successful therapy results. Use during the day ... maintain gains in motion. Available in small, medium ...
Medicine Products: